Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 121

1.
2.

Watchful waiting vs immediate transurethral resection for symptomatic prostatism. The importance of patients' preferences.

Barry MJ, Mulley AG Jr, Fowler FJ, Wennberg JW.

JAMA. 1988 May 27;259(20):3010-7.

PMID:
2452904
3.

Incorporating risk attitude into Markov-process decision models: importance for individual decision making.

Cher DJ, Miyamoto J, Lenert LA.

Med Decis Making. 1997 Jul-Sep;17(3):340-50.

PMID:
9219195
4.

Markov models in medical decision making: a practical guide.

Sonnenberg FA, Beck JR.

Med Decis Making. 1993 Oct-Dec;13(4):322-38.

PMID:
8246705
5.

[Decision analysis in radiology using Markov models].

Golder W.

Rofo. 2000 Jan;172(1):80-5. German.

PMID:
10719468
6.

Use of Bayesian Markov chain Monte Carlo methods to estimate EQ-5D utility scores from EORTC QLQ data in myeloma for use in cost-effectiveness analysis.

Kharroubi SA, Edlin R, Meads D, Browne C, Brown J, McCabe C.

Med Decis Making. 2015 Apr;35(3):351-60. doi: 10.1177/0272989X15575285.

PMID:
25784746
7.

Modelling the effect of function and disease activity on costs and quality of life in rheumatoid arthritis.

Kobelt G, Lindgren P, Lindroth Y, Jacobson L, Eberhardt K.

Rheumatology (Oxford). 2005 Sep;44(9):1169-75. Epub 2005 Jun 14.

PMID:
15956093
8.

A decision analysis for treatment of clinically localized prostate cancer.

Kattan MW, Cowen ME, Miles BJ.

J Gen Intern Med. 1997 May;12(5):299-305.

9.

The CORE Diabetes Model: Projecting long-term clinical outcomes, costs and cost-effectiveness of interventions in diabetes mellitus (types 1 and 2) to support clinical and reimbursement decision-making.

Palmer AJ, Roze S, Valentine WJ, Minshall ME, Foos V, Lurati FM, Lammert M, Spinas GA.

Curr Med Res Opin. 2004 Aug;20 Suppl 1:S5-26.

PMID:
15324513
10.

The cost effectiveness and cost utility of valsartan in chronic heart failure therapy in Italy: a probabilistic markov model.

Pradelli L, Iannazzo S, Zaniolo O.

Am J Cardiovasc Drugs. 2009;9(6):383-92. doi: 10.2165/11315730-000000000-00000.

PMID:
19929036
11.

Cost-effectiveness of interferon-alpha and conventional chemotherapy in chronic myelogenous leukemia.

Kattan MW, Inoue Y, Giles FJ, Talpaz M, Ozer H, Guilhot F, Zuffa E, Huber SL, Beck JR.

Ann Intern Med. 1996 Oct 1;125(7):541-8.

PMID:
8815752
12.

Stereotactic body radiotherapy versus surgery for medically operable Stage I non-small-cell lung cancer: a Markov model-based decision analysis.

Louie AV, Rodrigues G, Hannouf M, Zaric GS, Palma DA, Cao JQ, Yaremko BP, Malthaner R, Mocanu JD.

Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):964-73. doi: 10.1016/j.ijrobp.2010.06.040. Epub 2010 Oct 6.

PMID:
20932688
13.

Pilot study of a utilities-based treatment decision intervention for prostate cancer patients.

Knight SJ, Nathan DP, Siston AK, Kattan MW, Elstein AS, Collela KM, Wolf MS, Slimack NS, Bennett CL, Golub RM.

Clin Prostate Cancer. 2002 Sep;1(2):105-14.

PMID:
15046701
14.

How much does the type of tympanostomy tube matter? A utility-based Markov decision analysis.

Baik G, Brietzke S.

Otolaryngol Head Neck Surg. 2015 Jun;152(6):1000-6. doi: 10.1177/0194599814566594. Epub 2015 Jan 20.

PMID:
25605692
15.

Comparison of Markov model and discrete-event simulation techniques for HIV.

Simpson KN, Strassburger A, Jones WJ, Dietz B, Rajagopalan R.

Pharmacoeconomics. 2009;27(2):159-65. doi: 10.2165/00019053-200927020-00006.

PMID:
19254048
16.

The long-term cost effectiveness of treatments for benign prostatic hyperplasia.

DiSantostefano RL, Biddle AK, Lavelle JP.

Pharmacoeconomics. 2006;24(2):171-91. Review.

PMID:
16460137
17.

[Medical-economic models of benign prostatic hypertrophy].

Le Pen C, Lukacs B, Rumeau-Pichon C, Bonastre J.

Prog Urol. 1998 Dec;8(6):961-8. Review. French.

PMID:
9894254
18.

Surveillance of Barrett's oesophagus: exploring the uncertainty through systematic review, expert workshop and economic modelling.

Garside R, Pitt M, Somerville M, Stein K, Price A, Gilbert N.

Health Technol Assess. 2006 Mar;10(8):1-142, iii-iv. Review.

19.

SecondOpinion: interactive Web-based access to a decision model.

Scott GC, Cher DJ, Lenert LA.

Proc AMIA Annu Fall Symp. 1997:769-73.

20.

Prostate cancer screening: a decision analysis.

Cantor SB, Spann SJ, Volk RJ, Cardenas MP, Warren MM.

J Fam Pract. 1995 Jul;41(1):33-41.

PMID:
7798064

Supplemental Content

Support Center